Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

61.06
+0.23000.38%
Volume:1.18M
Turnover:71.55M
Market Cap:124.30B
PE:13.44
High:61.18
Open:60.65
Low:60.24
Close:60.83
52wk High:68.64
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:0.56
T/O Rate:0.06%
Dividend:2.51
Dividend Rate:4.11%
EPS(TTM):4.54
EPS(LYR):3.46
ROE:46.60%
ROA:10.72%
PB:5.57
PE(LYR):17.65

Loading ...

Bristol-Myers Squibb Extends Deucravacitinib Program, Signaling Long-Term Autoimmune Ambitions

TIPRANKS
·
Aug 28

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

Top Bristol-Myers Squibb Executive Makes Notable Move With Recent Stock Sale

TIPRANKS
·
Aug 27

Bristol Myers Squibb SVP, Controller Phil M. Holzer Sells 500 Shares for $33,750

Reuters
·
Aug 27

Bloomsbury Ties Executive Share Awards to Long-Term Performance Targets

TIPRANKS
·
Aug 26

Bristol Myers Squibb Stock (BMY) Looks Healthier After Ditching Blood Cancer Partner

TIPRANKS
·
Aug 26

Bristol Myers Ends Blood Cancer Drug Deal with Cell Therapy Maker Cellares

Reuters
·
Aug 26

Confirm That We Have Ended Our Partnership with Cellares. - Bristol Myers Spokesperson

THOMSON REUTERS
·
Aug 25

Bristol Myers Spokesperson: Determined Cellares-Partnered Cell Shuttle System Could not Meet Necessary Requirements to Make Commercial Breyanzi

THOMSON REUTERS
·
Aug 25

Bristol-Myers Squibb Adds Early Alzheimer’s Antibody To Its Long-Term Growth Story

TIPRANKS
·
Aug 22

Movement Alert|Bristol-Myers Squibb Rises 3.02% in Regular Trading, AI Antibody R&D Partnership and Sector Strength Fuel Rally

Market Focus
·
Aug 21

Bristol Myers Squibb Co. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 21

Bristol-Myers Squibb Co Stock (BMY) Closed Down by 3.17% on Aug 20: Facts Behind the Movement

TradingKey
·
Aug 21

Movement Alert|Bristol-Myers Squibb Falls 3.03% in Regular Trading, Pharmaceutical Sector Broadly Under Pressure

Market Focus
·
Aug 21

Bristol‑Myers Squibb Advances Navlimetostat Metabolism Study, Signaling Steady Pipeline Progress

TIPRANKS
·
Aug 21

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

Chai Discovery Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery

Reuters
·
Aug 20

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 20

Movement Alert|Bristol-Myers Squibb Rises 3.11% in Regular Trading, Zenbexus Gains FDA Accelerated Approval as Pharma Sector Rallies

Market Focus
·
Aug 19

Hengrui Pharma FY26 H1 Profit Attributable to Owners Rises 0.3% to RMB 4.47 Billion; Revenue Falls 1.9% to RMB 15.46 Billion

Reuters
·
Aug 19